Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits.
aortic stenosis
aortic valve surgery
echocardiography
heart valve disease
paradoxical low-flow low-gradient
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
01
2022
accepted:
07
02
2022
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
19
4
2022
Statut:
epublish
Résumé
To determine the risk of mortality and need for aortic valve replacement (AVR) in patients with low-flow low-gradient (LFLG) aortic stenosis (AS). A longitudinal multicentre study including consecutive patients with severe AS (aortic valve area [AVA] < 1.0 cm Of 1,391 patients, 147 (10.5%) had LFLG, 752 (54.1%) HG, and 492 (35.4%) NFLG. Echocardiographic parameters of the LFLG group showed similar AVA to the HG group but with less severity in the dimensionless index, calcification, and hypertrophy. The HG group required AVR earlier than NFLG ( Paradoxical LFLG AS affects 10.5% of severe AS, and has a lower need for AVR than the HG group and similar to the NFLG group, with no differences in mortality. AVR had a lower impact on LFLG AS compared with HG AS. Therefore, the findings of the present study showed LFLG AS to have an intermediate clinical risk profile between the HG and NFHG groups.
Identifiants
pubmed: 35433871
doi: 10.3389/fcvm.2022.852954
pmc: PMC9011160
doi:
Types de publication
Journal Article
Langues
eng
Pagination
852954Informations de copyright
Copyright © 2022 Galian-Gay, Escalona Silva, Teixidó-Turà, Casas, Ferrer-Sistach, Mitroi, Mingo, Monivas, Saura, Vidal, Trasca, Moral, Calvo, Castiñeira Busto, Sánchez, Gonzalez, Guzman, Mora, Arnau Vives, Peteiro, Bouzas, Mas-Stachurska, González-Alujas, Gutiérrez, Fernandez-Galera, Valente, Guala, Ruiz-Muñoz, Avilés, Palomares, Ferreira and Evangelista.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JACC Cardiovasc Imaging. 2019 Jan;12(1):84-92
pubmed: 30621997
J Am Coll Cardiol. 2012 Jan 17;59(3):235-43
pubmed: 22240128
Circulation. 2021 Feb 2;143(5):e72-e227
pubmed: 33332150
Circulation. 2011 Mar 1;123(8):887-95
pubmed: 21321152
Circulation. 2013 Oct 15;128(16):1781-9
pubmed: 24048203
JACC Cardiovasc Imaging. 2017 Nov;10(11):1320-1333
pubmed: 28017384
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
J Thorac Cardiovasc Surg. 2015 Jun;149(6):1558-66.e1
pubmed: 25869085
Am J Cardiol. 2015 Sep 15;116(6):925-32
pubmed: 26219495
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):859-867
pubmed: 28950306
J Am Coll Cardiol. 2013 Sep 10;62(11):1002-12
pubmed: 23727214
Int J Cardiovasc Imaging. 2018 Apr;34(4):545-552
pubmed: 29124471
J Am Coll Cardiol. 2017 May 16;69(19):2383-2392
pubmed: 28494976
Int J Cardiol. 2017 Dec 1;248:211-215
pubmed: 28864136
J Am Coll Cardiol. 2015 Jan 6;65(1):55-66
pubmed: 25572511
J Am Coll Cardiol. 2019 Oct 15;74(15):1851-1863
pubmed: 31491546
Circulation. 2007 Jun 5;115(22):2856-64
pubmed: 17533183
Sci Rep. 2017 Jul 11;7(1):5092
pubmed: 28698585
Circ Cardiovasc Imaging. 2015 Apr;8(4):
pubmed: 25852129
Circ Cardiovasc Imaging. 2014 Jul;7(4):714-22
pubmed: 24777938
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1094-1101
pubmed: 31327014
J Am Coll Cardiol. 2013 Dec 17;62(24):2329-38
pubmed: 24076528
Circ Cardiovasc Imaging. 2013 Nov;6(6):1009-17
pubmed: 24100045
J Am Coll Cardiol. 2012 Oct 2;60(14):1259-67
pubmed: 22657269
JACC Cardiovasc Imaging. 2014 Nov;7(11):1151-66
pubmed: 25459597
Heart. 2016 Jun 15;102(12):934-42
pubmed: 27048774
J Am Coll Cardiol. 2018 Mar 27;71(12):1313-1321
pubmed: 29566814